Assoc. Prof. Dr. Çiğdem İleri Doğan is a cardiologist at Liv Hospital Vadistanbul in Istanbul, Turkey, with a clinical focus on cardiovascular imaging, echocardiography, heart valve diseases, and heart failure.
She graduated first in her class from Istanbul University Cerrahpaşa Faculty of Medicine in 2011 and completed her Cardiology specialization at Marmara University Pendik Training and Research Hospital in 2016.
Her clinical interests include transthoracic echocardiography, transesophageal echocardiography, and stress echocardiography, as well as the diagnosis and monitoring of valvular heart diseases and heart failure.
She also focuses on cardiovascular care during pregnancy, women's heart health, and cardio-oncology, including cardiac monitoring of patients undergoing cancer treatment.
Her scientific publications cover cardiovascular imaging, cardiac rhythm abnormalities, and heart-related complications of ischemic stroke.
Education and Academic Qualifications
- Cardiology Specialization, Department of Cardiology, Marmara University Pendik Training and Research Hospital, 2016
- Doctor of Medicine, Department of Medicine (English), Istanbul University, Cerrahpasa Faculty of Medicine, 2011 (Graduated first in class)
- Adult Transthoracic Echocardiography Certificate, European Society of Cardiology, 2018
- Heart Failure Certificate, European Society of Cardiology, 2018
- Best Study Award, European Society of Cardiology, Heart and Stroke Congress, Budapest, 2022
Areas of Interest
-
Cardiac imaging and echocardiography in Turkey.
-
Transthoracic echocardiography (TTE).
-
Transesophageal echocardiography (TEE).
-
Stress echocardiography.
-
Heart valve disease diagnosis in Turkey.
-
Heart valve stenosis assessment.
-
Heart valve regurgitation assessment.
-
Heart failure diagnosis and management in Turkey.
-
Cardiac function assessment.
-
Heart muscle dysfunction evaluation.
-
Heart disease management during pregnancy in Turkey.
-
Cardiovascular assessment during pregnancy.
-
Women's heart health.
-
Cardio-oncology in Turkey.
-
Cardiac monitoring during cancer treatment.
-
Cancer therapy-related cardiac dysfunction assessment.